Search Results

You searched for : PharmaNews  

A ₹100-Crore Question: Are GLP-1 Injections Becoming India’s New Lifeline?

The obesity epidemic is vast. The solutions are emerging. Science is evolving. And the market is expanding. The launch of Yurpeak is another step in ...
Dec 12

Mankind’s Bet on Women’s Health: The ₹797-Crore Investment That Could Redefine India’s Pharma Future

In an industry where innovation often hides behind profit margins, Mankind’s bet on women’s health stands out as both a strategic and ethical ...
Oct 16

Indian Innovation vs Western Monopolies: Lupin’s FDA Triumph Tells a Bigger Story

Rivaroxaban under a generic label can significantly reduce treatment costs for patients, insurers, and government healthcare programs, all while maintaining the efficacy and safety standards ...
Jun 03

Novartis India Limited signs exclusive sales and distribution agreement with Dr. Reddy’s Laboratories

...
Feb 14

Asymchem Acquires Snapdragon Chemistry

Latest Corporate News update ; Pharma...
Feb 14

Novo Nordisk announces completion of Dicerna Pharmaceuticals acquisition

Latest pharma news update...
Dec 30

Hyloris announces FDA acceptance of new drug application for Maxigesic IV in post-operative pain

Latest pharma news update...
Nov 03

Everest Medicines enters into agreement with Providence Therapeutics to advance mRNA vaccines and Therapies

Latest Pharma News Update...
Sep 16

Precision BioSciences and Tiziana Life Sciences announce exclusive license agreement to evaluate Foralumab

Latest pharma Update...
Sep 06

Dupixent significantly improved itch and hives in patients with chronic spontaneous urticaria

Fifth disease that Dupixent has demonstrated positive pivotal results....
Jul 29

Biocon Biologics and Viatris Inc. Receive Historic Approval for First Interchangeable Biosimilar Semglee for the Treatment of Diabetes

Interchangeable Designation Allows Substitution at the Pharmacy Counter for Lantus Across the U.S. to Help Increase Access to Medicines for People Living with Diabetes...
Jul 29

Biocon Biologics and Viatris Inc. Receive Historic Approval for First Interchangeable Biosimilar Semglee for the Treatment of Diabetes

Interchangeable Designation Allows Substitution at the Pharmacy Counter for Lantus Across the U.S. to Help Increase Access to Medicines for People Living with Diabetes...
Jul 29

Dupixent significantly improved itch and hives in patients with chronic spontaneous urticaria

Fifth disease that Dupixent has demonstrated positive pivotal results....
Jul 29

BioNTech to acquire Kite’s neoantigen TCR Cell Therapy R&D platform and manufacturing facility in Gaithersburg, MD

Pharma merger and acquisition news...
Jul 22

Status on FDA Advisory Committee vote on roxadustat in anaemia of chronic kidney disease

New solutions are needed for the six million people in the US affected by anaemia of chronic kidney disease....
Jul 17

Bristol Myers Squibb Provides Update on CheckMate -651 Trial Evaluating Opdivo Plus Yervoy Versus EXTREME Regimen as First-Line Treatment for Squamous Cell Carcinoma

...
Jul 17

Merck Announces U.S. FDA Approval of VAXNEUVANCE for the Prevention of Invasive Pneumococcal Disease in Adults 18 Years and Older

Pneumococcal disease is an infection caused by bacteria called Streptococcus pneumoniae, or pneumococcus....
Jul 17

Sanofi streamlines Consumer Healthcare portfolio in Latin America with divestiture of eight brands to Hypera Pharma

As discussed during our Capital Markets Day in February, simplifying the CHC product portfolio is an important part of our strategy to focus our resources ...
Jul 14

Lupin Launches Tavaborole Topical Solution in the United States

The product will be manufactured at Lupin’s facility in Pithampur, India...
Jul 14

Stallergenes Greer and ALYATEC announce collaboration in allergen immunotherapy

With this collaboration, Stallergenes Greer aims to strengthen its precision medicine-based approach ...
Jul 12

Standigm Secures Strategic Investment from SK Chemicals for Expanding its AI-Drug Development Capacity

Pharma News update : Strategic Investments...
Jul 05

Forxiga recommended for approval in the EU by CHMP for the treatment of patients with chronic kidney disease

If approved, Forxiga has the potential to change the treatment paradigm for millions of people in the EU suffering from chronic kidney disease...
Jun 28

Dr. Reddy’s Laboratories Announces Commercial Launch of 2DG

2-DG is yet another addition to our COVID-19 portfolio that already covers the full spectrum of mild to moderate and severe conditions and ...
Jun 28

Dr. Reddy’s Laboratories Announces Commercial Launch of 2DG

2-DG is yet another addition to our COVID-19 portfolio that already covers the full spectrum of mild to moderate and severe conditions and ...
Jun 28

Bristol Myers Squibb Receives Positive CHMP Opinion for Anti-BCMA CAR T Cell Therapy Abecma for Relapsed and Refractory Multiple Myeloma

...
Jun 25

25 Matching result(s) found!

-Advertisements-



Trending Now

Healthcare AI Hallucinations: What Happens When an Algorithm Gets Medicine Wrong?September 22, 2026
How Indian Hospitals Are Building Responsible AI Governance FrameworksSeptember 22, 2026
Curapod M Launches to Change What Women Have Had to Live With for GenerationsSeptember 21, 2026
4,000 Thyroid Surgeries, 4,000 Stories: BMH Calicut Celebrates a Decade of Endocrine Surgery with Patients and FamiliesSeptember 21, 2026
Thumbay College of Veterinary Medicine Students Will Now Learn to Heal Animals the Way Top Specialists DoSeptember 20, 2026
Alma Lasers’ Accent Prime Introduced in Gurugram for Non-Surgical Body Contouring and Skin TighteningSeptember 19, 2026
Puresta Launches EVERQ To Change How India Approaches Skincare - Diagnose First, Then Treat September 19, 2026
From Eye Screening to Blood Sugar Insights: Forus Health and Eyebetes Foundation Pilot Retinal HbA1c Screening at Mumbai’s Ganpati PandalsSeptember 18, 2026
ShardaCare – Healthcity Screens 100+ People at Free Cardiac & Varicose Vein Screening Camp Ahead of World Heart DaySeptember 18, 2026
Beyond "Just a Viral Infection": When Common Childhood Illnesses Need Medical AttentionSeptember 18, 2026
Takeda and Dr. Reddy’s Laboratories Enter into Exclusive Collaboration to Promote and Distribute QDENGA® in India’s Pediatric and Adult Private MarketSeptember 18, 2026
Tier-2 and Tier-3 Cities: India's Next Big Healthcare Growth StorySeptember 18, 2026
Why Regional Hospital Chains Are Becoming More Important in IndiaSeptember 18, 2026
From Heart Defect to High Seas: Robot-Assisted Surgery at Fortis Escorts Okhla Helps 26-Year-Old Merchant Navy Officer Pursue His CareerSeptember 17, 2026
Apollo Hospitals, Bengaluru performs India’s first EXIME temporary prostatic stent procedure; five patients treatedSeptember 17, 2026
Rela Hospital and Smile Train Launch India’s Largest and Most Comprehensive Cleft Care Reference CentreSeptember 17, 2026
Max Healthcare Foundation Expands Max Medical Scholarship to Fund Education of 250 Meritorious MBBS Students in its 4th YearSeptember 17, 2026
The Future of Indian MedTech Exports: Can India Compete With Global Leaders?September 17, 2026
Robotic-Assisted Procedures Beyond Surgery: Where Is Automation Going Next in Healthcare?September 17, 2026
58 Students from SRM Medical College Selected for Union Government Research Programmes and Grants September 16, 2026